JZP-361

CAS No. 1680193-80-9

JZP-361( —— )

Catalog No. M34301 CAS No. 1680193-80-9

JZP-361 is a specific MAGL inhibitor with IC50s of 46 nM, 7.24 μM, and 1.79 μM for human recombinant MAGL, human recombinant FAAH, and human hABHD6.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 36 Get Quote
10MG 56 Get Quote
25MG 109 Get Quote
50MG 181 Get Quote
100MG 266 Get Quote
200MG 377 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    JZP-361
  • Note
    Research use only, not for human use.
  • Brief Description
    JZP-361 is a specific MAGL inhibitor with IC50s of 46 nM, 7.24 μM, and 1.79 μM for human recombinant MAGL, human recombinant FAAH, and human hABHD6.
  • Description
    JZP-361 is a potent, reversible and selective inhibitor of human recombinant MAGL (hMAGL) with an IC50 of 46 nM. JZP-361 also shows antihistaminergic activities and can be used for asthma research.
  • In Vitro
    JZP-361 has almost 150-fold higher selectivity over human recombinant fatty acid amide hydrolase (hFAAH, IC50 = 7.24 μM) and 35-fold higher selectivity over human α/β-hydrolase-6 (hABHD6, IC50 = 1.79 μM).JZP-361 retains H1 antagonistic affinity (pA2 = 6.81) but did not show cannabinoid receptor activity, when tested at concentrations ≤10 μM.JZP-361 displays favorable interactions within the active site of hMAGL including the important hydrogen-bonding of the carbonyl oxygen to the oxyanion hole.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Lipase
  • Recptor
    Lipase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1680193-80-9
  • Formula Weight
    405.88
  • Molecular Formula
    C22H20ClN5O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (307.97 mM; Ultrasonic (<60°C)
  • SMILES
    Clc1ccc2c(CCc3cccnc3C2=C2CCN(CC2)C(=O)n2cncn2)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jayendra Z Patel,?et al. Loratadine analogues as MAGL inhibitors. Bioorg Med Chem Lett.?2015 Apr 1;25(7):1436-42.?
molnova catalog
related products
  • JW 642

    JW 642 is an effective inhibitor of monoacylglycerol lipase (MAGL)

  • Lalistat 2

    Lalistat 2 is a selective inhibitor of lysosomal acid lipase with IC50 of 152 nM and exhibits no inhibition of human pancreatic lipase or bovine milk lipoprotein lipase (up to 10 μM).

  • JNJ-42226314

    JNJ-42226314 is a highly selective non-covalent monoacylglycerol lipase (MAGL) inhibitor with anti-injury effects.